The role of the intravascular system as a potential extracerebral route for transmission of tau pathology is not clearly elucidated as studies showed no association or an increased risk for AD after blood transfusion in cohort studies (O’Meara et al., 1997; Edgren et al., 2016; Lin et al., 2019). The gene discussed is MAPT; the disease is Alzheimer disease.